Some Medicare patients will be able to access GLP-1 medication for weight loss for the first time starting July 1, paying a $50 monthly copay through a new program designed to make the drugs more affordable
It provides real-time, personalized insights into how food, sleep and activity affect the body
Peptide Therapies for IGF-1 Optimization Peptides can help modulate growth hormone release, thereby influencing IGF-1
Victoza (liraglutide), the first GLP-1 for type 2 diabetes to lose exclusivity in June 2024, may not generate significant savings due to its once-daily dosing and limited market share
Material is fulfilled through Florida Compounding Company (part of US Compounding Company) in Jacksonville, FL, with batch-traceable, controlled handling